We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TXMD market cap is 48.52M. The company's latest EPS is USD -0.2351 and P/E is -4.64.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | -53k | 502k | 313k | 234k | 547k |
| Operating Income | -1.77M | -1.61M | -1.14M | -2.44M | -859k |
| Net Income | -3.38M | -883k | -734k | -1.09M | -609k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 49.65M | 64.87M | 86.95M | 69.96M | 1.3M |
| Operating Income | -151.21M | -155.54M | -139.77M | 1.19M | -8.52M |
| Net Income | -176.15M | -183.52M | -172.42M | 112M | -10.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50.49M | 43.31M | 42.09M | 40.13M | 39.55M |
| Total Liabilities | 22.44M | 14.02M | 13.42M | 12.46M | 12.46M |
| Total Equity | 28.05M | 29.29M | 28.66M | 27.67M | 27.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 265.99M | 181.61M | 169.47M | 90.46M | 43.31M |
| Total Liabilities | 256.79M | 305.61M | 263.09M | 55.32M | 14.02M |
| Total Equity | 9.2M | -124M | -93.62M | 35.14M | 29.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.3M | -23.08M | 11k | 905k | 720k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.15M | -21.91M | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -165.7M | -159.47M | -142.69M | 9.36M | -23.08M |
| Investing | -23.91M | -1.6M | -2.22M | -355k | N/A |
| Financing | 188.83M | 80.72M | 129.55M | -24.81M | -21.91M |
| Market Cap | 48.52M |
| Price to Earnings Ratio | -4.64 |
| Price to Sales Ratio | 36.58 |
| Price to Cash Ratio | 11.01 |
| Price to Book Ratio | 1.63 |
| Dividend Yield | - |
| Shares Outstanding | 43.72M |
| Average Volume (1 week) | 3.95M |
| Average Volume (1 Month) | 929.98k |
| 52 Week Change | -51.32% |
| 52 Week High | 2.75 |
| 52 Week Low | 0.70 |
| Spread (Intraday) | 0.02 (1.77%) |
| Company Name | TherapeuticsMD Inc |
| Address |
318 n carson st carson city, nevada 89701 |
| Website | https://www.therapeuticsmd.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
